Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

Pharmacy at Karmanos Cancer Center

Actemra

Afinitor

Alecensa

Alunbrig

Aranesp

Benlysta

Bosulif

Braftovi

Cabometyx

Cosentyx

Enbrel

Erleada

Gilotrif

Ibrance

Ilumya

Imbruvica

Inlyta

Iressa

Jakafi

Kesimpta

Koselugo

Lenvima

Lonsurf

Lorbrena

Lynparza

Mayzent

Mekinist

Mektovi

Nerlynx

Nexavar

Nplate

Nubeqa

Ofev

Olumiant

Piqray

Promacta

Qinlock

Retevmo

Revlimid

Rozlytrek

Stelara

Sutent

Tabrecta

Tafinlar

Tagrisso

Talzenna

Tarceva

Tasigna

Tavalisse

Tecfidera

Temodar

Tibsovo

Tykerb

Venclexta

Verenzio

Vizimpro

Votrient

Xalkori

Xolair

Xpovio

Xtandi

Zejula

Zelboraf

Zydelig

Zykadia

Entyvio | Pharmacy at Karmanos Cancer Center

Which health plans does Pharmacy at Karmanos Cancer Center have contracts with?

Does Pharmacy at Karmanos Cancer Center work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does Pharmacy at Karmanos Cancer Center offer services for Entyvio patients?

What conditions does Pharmacy at Karmanos Cancer Center support?

How does Pharmacy at Karmanos Cancer Center help with insurance?